Bayerische Motoren Werke AG BYMOF Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Bayerische Motoren Werke AG BYMOF Company Overview 

Stock Message Board http://investorshangout.com/search?q=BYMOF&am...mp;yt1=Go!

Bayerische Motoren Werke AG BYMOF Current Price and Quotes
Last Price 74.00
Previous Close 74.00 Open N/A
Daily Range N/A - N/A 52wk Range 76.00 - 55.26
Volume 0 Dividend N/A
Average Vol (3m) 972 Yield N/A
Bayerische Motoren Werke AG BYMOF
Company Information

Petuelring 130
BMW-HAUS
Munich 80788
Germany

Website: http://www.bmwgroup.com
Phone: 4989-3822-5858
Find us on:    

Bayerische Motoren Werke AG BYMOF
Bayerische Motoren Werke AG BYMOF
Financial Reportings and Disclosures

Reporting Status International Reporting: Frankfurt Stock Exchange
CIK 0001446250
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification
Incorporated In: Germany
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Torsten Schuessler Head of IR
Company Directors

Norbert Reithofer Chairman
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Bayerische Motoren Werke AG BYMOF
BYMOF Security Details Other Company Securities

Share Structure

Market Value1 $44,547,644,800 a/o Sep 13, 2013
Shares Outstanding 601,995,200 a/o Sep 30, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

BMW - Frankfurt Stock Exchange - Qualified
Short Selling Data

Short Interest 325 (0.31%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Bayerische Motoren Werke AG BYMOF Recent News

Bayerische Motoren Werke AG BYMOF Financials
Data is unavailable at this time. Please check this page later.


BYMOF Bayerische Motoren Werke AG Research DD Guide

BYMOF Bayerische Motoren Werke AG Stock Message Board http://investorshangout.com/search?q=BYMOF&am...mp;yt0=Go!
BYMOF Bayerische Motoren Werke AG Stock Quote http://www.otcmarkets.com/stock/BYMOF/quote
BYMOF Bayerische Motoren Werke AG Stock Chart http://www.otcmarkets.com/stock/BYMOF/chart
BYMOF Bayerische Motoren Werke AG Company Info http://www.otcmarkets.com/stock/BYMOF/company-info
BYMOF Bayerische Motoren Werke AG Recent News http://www.otcmarkets.com/stock/BYMOF/news
BYMOF Bayerische Motoren Werke AG Financials http://www.otcmarkets.com/stock/BYMOF/financials
BYMOF Bayerische Motoren Werke AG Filings and Disclosure http://www.otcmarkets.com/stock/BYMOF/filings
BYMOF Bayerische Motoren Werke AG Short Sales http://www.otcmarkets.com/stock/BYMOF/short-sales
BYMOF Bayerische Motoren Werke AG Insider Disclosure http://www.otcmarkets.com/stock/BYMOF/insider-transactions
BYMOF Bayerische Motoren Werke AG Research Reports http://www.otcmarkets.com/stock/BYMOF/research
BYMOF Bayerische Motoren Werke AG Summary http://finance.yahoo.com/q?s=BYMOF
BYMOF Bayerische Motoren Werke AG Historical Prices http://finance.yahoo.com/q/hp?s=BYMOF+Historical+Prices
BYMOF Bayerische Motoren Werke AG Interactive Chart http://finance.yahoo.com/echarts?s=BYMOF
BYMOF Bayerische Motoren Werke AG Basic Chart http://finance.yahoo.com/q/bc?s=BYMOF+Basic+Chart
BYMOF Bayerische Motoren Werke AG Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BYMOF+Basic+Tech.+Analysis
BYMOF Bayerische Motoren Werke AG Headlines http://finance.yahoo.com/q/h?s=BYMOF+Headlines
BYMOF Bayerische Motoren Werke AG Press Releases http://finance.yahoo.com/q/p?s=BYMOF+Press+Releases
BYMOF Bayerische Motoren Werke AG Company Profile http://finance.yahoo.com/q/pr?s=BYMOF+Profile
BYMOF Bayerische Motoren Werke AG Key Statistics http://finance.yahoo.com/q/ks?s=BYMOF+Key+Statistics
BYMOF Bayerische Motoren Werke AG Industry http://finance.yahoo.com/q/in?s=BYMOF+Industry
BYMOF Bayerische Motoren Werke AG Major Holders http://finance.yahoo.com/q/mh?s=BYMOF+Major+Holders
BYMOF Bayerische Motoren Werke AG Insider Transactions http://finance.yahoo.com/q/it?s=BYMOF+Insider+Transactions
BYMOF Bayerische Motoren Werke AG Insider Roster http://finance.yahoo.com/q/ir?s=BYMOF+Insider+Roster
BYMOF Bayerische Motoren Werke AG Income Statement http://finance.yahoo.com/q/is?s=BYMOF
BYMOF Bayerische Motoren Werke AG Balance Sheet http://finance.yahoo.com/q/bs?s=BYMOF
BYMOF Bayerische Motoren Werke AG Cash Flow http://finance.yahoo.com/q/cf?s=BYMOF+Cash+Flow&annual
BYMOF Bayerische Motoren Werke AG Nasdaq http://www.nasdaq.com/symbol/BYMOF
BYMOF Bayerische Motoren Werke AG Market Watch http://www.marketwatch.com/investing/stock/BYMOF
BYMOF Bayerische Motoren Werke AG Bloomberg http://www.bloomberg.com/quote/BYMOF:US
BYMOF Bayerische Motoren Werke AG Morningstar http://quotes.morningstar.com/stock/s?t=BYMOF
BYMOF Bayerische Motoren Werke AG Bussinessweek http://investing.businessweek.com/research/st...cker=BYMOF
BYMOF Bayerische Motoren Werke AG Barchart http://www.barchart.com/quotes/stocks/BYMOF
BYMOF Bayerische Motoren Werke AG OTC Short Report http://otcshortreport.com/index.php?index=BYMOF
BYMOF Bayerische Motoren Werke AG Investopedia http://www.investopedia.com/markets/stocks/BYMOF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading